Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Am J Clin Nutr. 2022 Apr 1;115(4):1123-1133. doi: 10.1093/ajcn/nqab389.
Vitamin D may have a role in immune responses to viral infections. However, data on the association between vitamin D and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) severity have been limited and inconsistent.
We examined the associations of predicted vitamin D status and intake with risk of SARS-CoV-2 infection and COVID-19 severity.
We used data from periodic surveys (May 2020 to March 2021) within the Nurses' Health Study II. Among 39,315 participants, 1768 reported a positive test for SARS-CoV-2 infection. Usual vitamin D intake from foods and supplements were measured using a semiquantitative, pre-pandemic food-frequency questionnaire in 2015. Predicted 25-hydroxyvitamin D [25(OH)D] concentration were calculated based on a previously validated model including dietary and supplementary vitamin D intake, UV-B, and other behavioral predictors of vitamin D status.
Higher predicted 25(OH)D concentrations, but not vitamin D intake, were associated with a lower risk of SARS-CoV-2 infection. Comparing participants in the highest quintile of predicted 25(OH)D concentrations with the lowest, the multivariable-adjusted OR was 0.76 (95% CI: 0.58, 0.99; P-trend = 0.04). Participants in the highest quartile of UV-B (OR: 0.76; 95% CI: 0.66, 0.87; P-trend = 0.002) and UV-A (OR: 0.76; 95% CI: 0.66, 0.88; P-trend < 0.001) also had a lower risk of SARS-CoV-2 infection compared with the lowest. High intake of vitamin D from supplements (≥400 IU/d) was associated with a lower risk of hospitalization (OR: 0.51; 95% CI: 0.29, 0.91; P-trend = 0.04).
Our study provides suggestive evidence on the association between higher predicted circulating 25(OH)D concentrations and a lower risk of SARS-CoV-2 infection. Greater intake of vitamin D supplements was associated with a lower risk of hospitalization. Our data also support an association between exposure to UV-B or UV-A, independently of vitamin D and SARS-CoV-2 infection, so results for predicted 25(OH)D need to be interpreted cautiously.
维生素 D 可能在病毒感染的免疫反应中发挥作用。然而,关于维生素 D 与严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染和 2019 年冠状病毒病(COVID-19)严重程度之间的关联的数据一直有限且不一致。
我们研究了预测的维生素 D 状况和摄入量与 SARS-CoV-2 感染和 COVID-19 严重程度的风险之间的关联。
我们使用了护士健康研究 II 中定期调查(2020 年 5 月至 2021 年 3 月)的数据。在 39315 名参与者中,有 1768 人报告 SARS-CoV-2 感染检测呈阳性。2015 年使用半定量、大流行前食物频率问卷测量了来自食物和补充剂的维生素 D 常规摄入量。根据先前验证的模型,计算了预测的 25-羟维生素 D [25(OH)D] 浓度,该模型包括膳食和补充维生素 D 摄入量、UV-B 和其他维生素 D 状态的行为预测因子。
较高的预测 25(OH)D 浓度,而不是维生素 D 摄入量,与 SARS-CoV-2 感染风险降低相关。与最低五分位数相比,将最高五分位数的预测 25(OH)D 浓度的参与者进行比较,多变量调整后的 OR 为 0.76(95%CI:0.58,0.99;P 趋势=0.04)。与最低五分位数相比,处于最高四分位数的 UV-B(OR:0.76;95%CI:0.66,0.87;P 趋势=0.002)和 UV-A(OR:0.76;95%CI:0.66,0.88;P 趋势<0.001)的参与者 SARS-CoV-2 感染风险也较低。高剂量的维生素 D 补充剂(≥400IU/d)与住院风险降低相关(OR:0.51;95%CI:0.29,0.91;P 趋势=0.04)。
我们的研究提供了关于循环 25(OH)D 浓度升高与 SARS-CoV-2 感染风险降低之间关联的提示性证据。维生素 D 补充剂摄入量较高与住院风险降低相关。我们的数据还支持 UV-B 或 UV-A 暴露与维生素 D 和 SARS-CoV-2 感染独立相关,因此需要谨慎解释预测 25(OH)D 的结果。